_PRIVATE_LIMITED.webp)
Sarvasya Trading (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -97.63%
(FY 2023)
- Profit 91.87%
(FY 2023)
- Ebitda 89.12%
(FY 2023)
- Net Worth -8.02%
(FY 2023)
- Total Assets -70.17%
(FY 2023)
About Sarvasya Trading (India)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Dobariya and Yogesh Panchal serve as directors at the Company.
- CIN/LLPIN
U51902GJ2017PTC098785
- Company No.
098785
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sarvasya Trading (India) Private Limited offer?
Sarvasya Trading (India) Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Anti Infective Drugs & Medicines, Malaria Medicine, Pain Relief Drugs & Pharmaceuticals, Anesthetic, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Blood Pressure Medicine.
Who are the key members and board of directors at Sarvasya Trading (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Panchal  | Director | 22-Aug-2017 | Current |
| Rohit Dobariya | Director | 22-Aug-2017 | Current |
Financial Performance of Sarvasya Trading (India).
Sarvasya Trading (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.63% decrease. The company also saw a substantial improvement in profitability, with a 91.87% increase in profit. The company's net worth dipped by a decrease of 8.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarvasya Trading (India)?
In 2023, Sarvasya Trading (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mecoson Pharmaceuticals Private LimitedActive 4 years 3 monthsRohit Dobariya and Yogesh Panchal are mutual person
Mecoson Labs Private LimitedActive 6 years 1 monthRohit Dobariya and Yogesh Panchal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarvasya Trading (India)?
Unlock and access historical data on people associated with Sarvasya Trading (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarvasya Trading (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarvasya Trading (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
